Distinct SARS-CoV-2 sensing pathways in pDCs driving TLR7-antiviral vs. TLR2-immunopathological responses in COVID-19
Renée M. van der Sluis(Aarhus University), Martin R. Jakobsen(Aarhus University), Lasse S. Kristensen(Aarhus University), Janni J. Jørgensen(Aarhus University), Martin Tolstrup(Aarhus University), Ulvi Ahmadov(German Cancer Research Center), Anders Laustsen(Aarhus University), Line S. Reinert(Aarhus University), Christian K. Holm(Aarhus University), Rasmus O. Bak(Aarhus University), Albert Gris Oliver(Aarhus University), Jacob Thyrsted(Aarhus University), Stine H. Godsk(Aarhus University), Lamin B. Cham(University of Duisburg-Essen), Ole S. Søgaard(Aarhus University Hospital), Tobias Wang Bjerg(Aarhus University), Jesper Damsgaard Gunst(Aarhus University), Søren R. Paludan(Aarhus University), Ena Cémalovic(Aarhus University), Manja Idorn(Aarhus University), Sabine Sanches Hernandez(Aarhus University), Kristine Raaby Gammelgaard(Aarhus University), David Olagnier(Aarhus University), Jesper G Pedersen(Aarhus University), Mads Kjølby(Aarhus University)
Cited by 2
Related Papers
Circular RNAs in cancer: opportunities and challenges in the field
|Oncogene|2017|1.4k
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
|Molecular Cell|2018|663
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
|PLoS Pathogens|2015|522